跳轉至內容
Merck
  • Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis.

Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis.

Clinical rheumatology (1983-12-01)
O Laitinen, E Seppalä, M Nissilä, H Vapaatalo
摘要

No significant differences were found in plasma concentrations and urinary excretion of prostaglandin E2 (PGE2), 6-keto-prostaglandin-F1 alpha (6-keto-PGF1 alpha) and thromboxane B2 (TxB2), between rheumatoid arthritis patients and controls. However, urinary excretion of PGEe and 6-keto-PGF1 alpha tended to be greater and plasma levels of TxB2 lower in rheumatoid arthritis. Plasma concentrations and urinary excretion showed no marked circadian variation, although night or morning values were slightly lower. Plasma and urine prostaglandins do not correlate with clinical symptomatology in rheumatoid arthritis.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
17α-羟基孕酮, ≥95%
Sigma-Aldrich
Cortisone, ≥95%
Supelco
雄烯二酮标准液 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
17α-羟孕酮标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
4-雄烯-3,17-二酮, VETRANAL®, analytical standard